PK/PD analysis of biapenem in patients undergoing continuous hemodiafiltration

BACKGROUND: Continuous hemodiafiltration (CHDF) is used as renal replacement therapy for critically ill patients with renal failure, and to treat hypercytokinemia. Since CHDF also clears therapeutic agents, drug pharmacokinetics (PK) should be dependent upon CHDF conditions. Although the antibiotic...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Pharm Health Care Sci
Autori principali: Akashita, Gaku, Hosaka, Yuto, Noda, Toru, Isoda, Kazuya, Shimada, Tsutomu, Sawamoto, Kazuki, Miyamoto, Ken-ichi, Taniguchi, Takumi, Sai, Yoshimichi
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2015
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4728804/
https://ncbi.nlm.nih.gov/pubmed/26819742
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40780-015-0031-6
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi